In obese and hyperglycemic mice, the administration of anti-resistin antibody reduced glucose level and improved insulin sensitivity, indirectly suggesting that elevated resistin levels played a causative role in the high risk of obesity-related T2DM [107]. The gene discussed is RETN; the disease is obesity disorder.